Godschalk R W, Dallinga J W, Wikman H, Risch A, Kleinjans J C, Bartsch H, Van Schooten F J
Department of Health Risk Analysis and Toxicology, Maastricht University, Maastricht, The Netherlands.
Pharmacogenetics. 2001 Jul;11(5):389-98. doi: 10.1097/00008571-200107000-00003.
The formation of DNA and protein adducts by environmental pollutants is modulated by host polymorphisms in genes that encode metabolizing enzymes. In our study on 67 smokers, aromatic-DNA adduct levels were examined by nuclease P1 enriched 32P-postlabelling in mononuclear blood cells (MNC) and 4-aminobiphenyl-haemoglobin adducts (4-ABP-Hb) by gas chromatography-mass spectroscopy. Genetic polymorphisms in glutathione S-transferase M1 (GSTM1), T1 (GSTT1) and N-acetyl-transferase 1 (NAT1) and 2 (NAT2) were assessed by polymerase chain reaction-based methods. DNA adduct levels, adjusted for the amount of cigarettes smoked per day, were higher in GSTM1(-/-) individuals (1.30 +/- 0.57 adducts per 108 nucleotides) than in GSTM1(+) subjects (1.03 +/- 0.56, P = 0.05), higher in NAT1 slow acetylators (1.58 +/- 0.54) than in NAT1 fast acetylators (1.11 +/- 0.58, P = 0.05) and were also found to be associated with the NAT2 acetylator status (1.29 +/- 0.64 and 1.03 +/- 0.46, respectively, for slow and fast acetylators, P = 0.06). An effect of GSTT1 was only found in combination with the NAT2 genotype; individuals with the GSTT1(-/-) and NAT2-slow genotype contained higher adduct levels (1.80 +/- 0.68) compared to GSTT1(+)/NAT2 fast individuals (0.96 +/- 0.36). Highest DNA adduct levels were observed in slow acetylators for both NAT1 and NAT2 also lacking the GSTM1 gene (2.03 +/- 0.17), and lowest in GSTM1(+) subjects with the fast acetylator genotype for both NAT1 and NAT2 (0.91 +/- 0.45, P = 0.01). No overall effects of genotypes were observed on 4-ABP-Hb levels. However, in subjects smoking less than 25 cigarettes per day, 4-ABP-Hb levels were higher in NAT2 slow acetylators (0.23 +/- 0.10 ng/g Hb) compared to fast acetylators (0.15 +/- 0.07, P = 0.03). These results provide further evidence for the combined effects of genetic polymorphisms in GSTM1, GSTT1, NAT1 and NAT2 on DNA and protein adduct formation in smoking individuals and indicate that, due to the complex carcinogen exposure, simultaneous assessment of multiple genotypes may identify individuals at higher cancer risk.
环境污染物形成的DNA和蛋白质加合物受编码代谢酶的基因中宿主多态性的调节。在我们对67名吸烟者的研究中,通过核酸酶P1富集的32P后标记法检测单核血细胞(MNC)中的芳香族DNA加合物水平,并用气相色谱 - 质谱法检测4-氨基联苯 - 血红蛋白加合物(4-ABP-Hb)。通过基于聚合酶链反应的方法评估谷胱甘肽S-转移酶M1(GSTM1)、T1(GSTT1)以及N-乙酰转移酶1(NAT1)和2(NAT2)的基因多态性。经每日吸烟量校正后,GSTM1(-/-)个体的DNA加合物水平(每108个核苷酸1.30±0.57个加合物)高于GSTM1(+)受试者(1.03±0.56,P = 0.05),NAT1慢乙酰化者的DNA加合物水平(1.58±0.54)高于NAT1快乙酰化者(1.11±0.58,P = 0.05),并且还发现其与NAT2乙酰化状态相关(慢乙酰化者和快乙酰化者分别为1.29±0.64和1.03±0.46,P = 0.06)。仅在与NAT2基因型联合时发现GSTT1有影响;GSTT1(-/-)和NAT2慢基因型个体的加合物水平(1.80±0.68)高于GSTT1(+)/NAT2快基因型个体(0.96±0.36)。在同时缺乏GSTM1基因的NAT1和NAT2慢乙酰化者中观察到最高的DNA加合物水平(2.03±0.17),而在NAT1和NAT2均为快乙酰化基因型的GSTM1(+)受试者中最低(0.91±0.45,P = 0.01)。未观察到基因型对4-ABP-Hb水平的总体影响。然而,在每日吸烟少于25支的受试者中,NAT2慢乙酰化者的4-ABP-Hb水平(0.23±0.10 ng/g Hb)高于快乙酰化者(0.15±0.07,P = 0.03)。这些结果为GSTM1、GSTT1、NAT1和NAT2基因多态性对吸烟个体中DNA和蛋白质加合物形成的联合作用提供了进一步证据,并表明由于致癌物暴露复杂,同时评估多种基因型可能识别出癌症风险较高的个体。